On
the other hand, the elevated MCP-1 may be a result of the
increased body fat caused by the high-fat diet and the reduction of
MCP-1 by EGCG treatment may be secondary to the decrease in
adipose tissue. Future studies are needed to clearly determine
whether EGCG elicits its metabolic effects by attenuation of
inflammation.